Target intelligence / Profile preview

Macular pigment optical density (MPOD)

Target
MPOD
Molecular classification
Other
01

Overview

Macular pigment optical density (MPOD) is not a molecule or receptor, but rather a quantitative measure of the concentration of specific dietary carotenoids—lutein, zeaxanthin, and meso-zeaxanthin—within the central retina (macula), especially in the fovea. These pigments act as internal "sunglasses," filtering out harmful blue light and providing antioxidant protection to photoreceptors. Higher MPOD is associated with better visual performance—including improved visual acuity, contrast sensitivity, glare recovery, reduced photophobia—and lower risk for age-related eye diseases such as age-related macular degeneration (AMD)[1][2][4]. The body cannot synthesize these carotenoids; they must be obtained from diet or supplementation. Measurement of MPOD serves as a non-invasive biomarker for assessing retinal defense mechanisms against oxidative stress but does not represent a therapeutic target like an enzyme or receptor would. Interventions focus on increasing dietary intake or supplementation with lutein and zeaxanthin to raise MPOD levels in at-risk individuals[1][2]. "Macular pigment is comprised of two dietary carotenoids, zeaxanthin and lutein... Healthy pigment functions like 'internal sunglasses', screening photoreceptors from oxidation and potential harm."[1] "The role of the [macular] pigment in the human eye is well described... It acts as an antioxidant by quenching reactive oxygen species and as a filter for damaging high energy/short-wavelengths of visible light (blue light)."[2] Because MPOD refers to a measurement/biomarker rather than an actionable molecular target, it should not be classified alongside receptors or enzymes. If you are seeking information about one of its constituent molecules—such as lutein or zeaxanthin—or about specific proteins involved in their transport/metabolism within the retina, those would be more appropriate molecular targets. Note: There is something incorrect about using "Macular pigment optical density" as if it were itself a druggable target; it describes a property measured clinically rather than any single molecule/protein/receptor amenable to direct pharmacological modulation.[7]

Other names
macular pigment densityMPODmacular pigment concentrationmacular carotenoid density
02

Mechanism of action

Dietary supplementation increases retinal carotenoid levels, raising MPOD and enhancing blue light filtration and antioxidant capacity

03

Biological functions

Blue light filtrationAntioxidant protectionVisual acuity enhancementGlare reductionPhotophobia attenuation
04

Disease associations

Age-related macular degeneration (AMD)Vision loss with aging
05

Interacting drugs

Lutein supplements

1 more in the full profile.

06

Biomarkers

Macular pigment optical density (MPOD) is itself a biomarker for retinal health and risk of AMD

Beyond the preview

Go deeper on Macular pigment optical density (MPOD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macular pigment optical density (MPOD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call